The study discusses the need for self-administration of alpha-1 antitrypsin (AAT) therapy, which can improve patient quality of life by reducing the frequency of hospital visits for infusions.
The research involved 25 experts—including pulmonologists, nurses, and pharmacists—who participated in online meetings to form recommendations about patient selection, healthcare roles, training, and logistics.
The aim is to raise awareness of self-administration as an option for AAT therapy, enhance patient experiences, and encourage further research to optimize these programs.